Epigenetics in cancer therapy and nanomedicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epigenetics in cancer therapy and nanomedicine

Published:2019-05-16 Issue:1 Volume:11 Page:
ISSN:1868-7075
Container-title:Clinical Epigenetics
language:en
Short-container-title:Clin Epigenet

Author:

Roberti Annalisa,Valdes Adolfo F.,Torrecillas Ramón,Fraga Mario F.,Fernandez Agustin F.^ORCID

Funder

Plan Nacional de I+D+I FEDER

Gobierno del Principado de Asturias

Albert Einstein Cancer Center

FGCSIC

Miguel Servet II fellowship

Obra Social Cajastur-Liberbank, Spain

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Developmental Biology,Genetics,Molecular Biology

Link

http://link.springer.com/content/pdf/10.1186/s13148-019-0675-4.pdf

Reference151 articles.

1. Alabert C, Barth TK, Reveron-Gomez N, Sidoli S, Schmidt A, Jensen ON, Imhof A, Groth A. Two distinct modes for propagation of histone PTMs across the cell cycle. Genes Dev. 2015;29(6):585–90.

2. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell. 2007;128(4):669–81.

3. Budhavarapu VN, Chavez M, Tyler JK. How is epigenetic information maintained through DNA replication? Epigenetics Chromatin. 2013;6(1):32.

4. Hathaway NA, Bell O, Hodges C, Miller EL, Neel DS, Crabtree GR. Dynamics and memory of heterochromatin in living cells. Cell. 2012;149(7):1447–60.

5. Zhu B, Reinberg D. Epigenetic inheritance: uncontested? Cell Res. 2011;21(3):435–41.

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives;MedComm;2024-08-24

2. Selective Estrogen Receptor Modulators’ (SERMs) Influence on TET3 Expression in Breast Cancer Cell Lines with Distinct Biological Subtypes;International Journal of Molecular Sciences;2024-08-06

3. DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells;EMBO Molecular Medicine;2024-07-15

4. TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway;Cancer Science;2024-03-12

5. Nanomedicines as enhancers of tumor immunogenicity to augment cancer immunotherapy;Drug Discovery Today;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3